Frontiers Schizophrenia Increases Variability of the Central Antioxidant System: A Meta Analysis of Variance From MRS Studies of Glutathione The distance between a compound demonstrating efficacy in preclinical research and that compound appearing in a physician's standard toolkit can span a generation. The mechanisms by which NAC addresses oxidative stress, glutamate Glutathione and glutamate in schizophrenia: a 7T MRS study Molecular Psychiatry Glutathione: a novel treatment target in psychiatry: Trends in Pharmacological Sciences A Review in Nature Reviews Drug Discovery highlights new drugs for schizophrenia that target glutamatergic and cholinergic signaling, moving beyond traditional dopamine modulating treatments that only address some symptoms and have significant side From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment Neuropsychopharmacology